在药房实践中,使用三维混合器装置混合囊粉末混合物的可能性
概括
在FagronLabTM InvoMatic三维混合器有效准备均的口服粉末囊. 这种装置确保了内容的统一性,满足了药典中关于制药化合物的标准.
科学领域:
- 制药技术 制药技术 制药技术
- 复合药房 复合药房 复合药房
- 材料科学 材料科学 材料科学
背景情况:
- 囊填充需要均的粉末混合物,传统上依赖于手动混合.
- 药房复合越来越多地使用自动化设备,以提高效率和一致性.
- 该InvoMatic三维混合器是一个新的装置,用于制药粉末的混合.
研究的目的:
- 为了评估FagronLabTM InvoMatic口服粉末混合器的混合效果.
- 为了比较InvoMatic混合机的性能与手动混合方法.
- 评估填充剂和混合参数对粉末均性的影响.
主要方法:
- 使用InvoMatic设备与三个填充剂混合了一个模型物质 (晶体化).
- 混合周期的速度各不相同,时间不变为10分钟.
- 粉末的均性通过电位计定位进行评估,并与手动/陶珠混合相比较.
主要成果:
- 在InvoMatic混合器中,通常会产生足够均的混合物 (RSD1 ≤ 5),符合药典标准.
- 使用该设备制备的囊通过了内容一致性测试 (接受值<15).
- 指出了一个例外,这表明特定的填充器-设备相互作用的潜在影响.
结论:
- 在InvoMatic三维混合器是一个有效的工具,在囊制备中实现统一的粉末混合.
- 该设备为手动混合提供了可靠的替代方案,提高了制药化合物的一致性.
- 进一步的研究可能会探索各种填充剂-辅助剂组合的最佳参数.
相关概念视频
01:18Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
280
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
280
01:13In Vitro Drug Dissolution: Compendial Testing Models I
195
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
195
01:28Factors Influencing Drug Absorption: Pharmaceutical Parameters
377
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
377
01:27Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
134
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
134
01:30Mixing Concrete
348
Concrete mixing ensures a homogenous blend where aggregates are well-coated with cement paste. Concrete mixing is typically done using two main types of mixers: batch and continuous. Batch mixers handle one batch at a time, thoroughly combining materials before discharging and receiving the next batch. In contrast, continuous mixers receive a steady flow of ingredients, mixing them consistently and discharging without interruption. Within batch mixers, tilting drum mixers mix with internal...
348
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
656
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
656